13 November 2024 | Featured

Shaping infant futures: ImmunoIVD & Thermo Fisher Scientific’s qPCR innovations

Discover how ImmunoIVD and Thermo Fisher Scientific are making an impact on newborn screening and clinical diagnostics by watching the video below. See how ImmunoIVD develops effective assays used by laboratories to screen for severe combined immunodeficiency and spinal muscular atrophy. With these serious conditions, early diagnosis and treatment are pivotal to the life outcomes … Continued

Read more
Read
More

News

14 September 2024

CHU Grenoble Alps welcomes French laboratories wishing to gain practical experience of the SPOT-it™ screening kit.

ImmunoIVD and its French distributor, AdGeniX, had the pleasure of training a team at CHU Grenoble Alpes in the use of SPOT-it™ assay for severe combined immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA) newborn screening. The laboratory is now ready to accommodate other French laboratories wishing to gain hands-on experience with the SPOT-it™ Screening Kit.  … Continued

Read more

13 August 2024

ImmunoIVD receives ISO14001 certification and A- Score on ESG rating

We’re happy to announce that ImmunoIVD AB has officially received the ISO14001 certification from Svensk Certifiering. This certificate is a formal recognition of our long-standing commitment to sustainable practices and our dedication to protecting the environment. We strive to not only improve lives by providing reliable newborn screening assays but also to do so in … Continued

Read more
Events

Events

23

March

23

March

13th ISNS European Regional Meeting in Luxembourg

Location

European Congress Center Luxembourg

Description

Join us in Luxembourg in 2025 at the “Newborn screening LIVE in the heart of Europe” meeting.

Interested in Our Products?

Let us present you the details of our offer

Meet us and talk.